PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-01

Date Title Company
01-Oct-2025 Lord Hague of Richmond officially opens £1.2 billion Oxford North flagship global innovation district in major boost to UK science, technology & AI sectors Oxford North
01-Oct-2025 Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer Tessellate Bio
01-Oct-2025 Minebea Intec strengthens global sales with the return of Frank Wieland as CSO Minebea Intec
01-Oct-2025 Medical Care Technologies (OTC Pink:MDCE) Secures Access to One of the World's Largest Public Skin Cancer Image Databases to Accelerate AI Development ACCESS Newswire
01-Oct-2025 L&T Technology Services Wins USD 100 Million Multi-Year Program from US-Based Industrial Equipment Manufacturer Businesswire
01-Oct-2025 Cancer AI Alliance Unveils First Collaborative AI Platform for Cancer Research ACCESS Newswire
01-Oct-2025 CareChoice Expands Into Michigan With New Detroit Office Opening October 1 ACCESS Newswire
01-Oct-2025 Coulter Partners places Managing Director of Parkinson’s UK Coulter Partners
01-Oct-2025 PACE Announces £6 Million Funding for Antibacterial Treatment Innovations to Fill Critical Gap in R&D Pipeline Medicines Discovery Catapult
01-Oct-2025 eschbach Unites Manufacturing Teams With New Batch Tracking Solution for Shiftconnector® eschbach
01-Oct-2025 Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia Tiziana Life Sciences
01-Oct-2025 Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025 Kuros Biosciences
01-Oct-2025 Who is the Best FTM Top Surgeon? ACCESS Newswire
01-Oct-2025 Cognixion Launches Clinical Study Integrating Non-Invasive Brain-Computer Interface Technology ACCESS Newswire
01-Oct-2025 Stem Cell Banking Market Key Players Analysis, Opportunities and Growth Forecast to 2035 Market Business Insights
01-Oct-2025 Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication ACCESS Newswire
01-Oct-2025 Leqembi®▼(lecanemab) long-term 36-month open-label extension data from post-hoc sub-group analysis of ApoE ε4 non-carriers and heterozygotes presented at Alzheimer’s disease congress in Switzerland Eisai Europe Ltd.
01-Oct-2025 Champion Health CLO Emily Langdon Selected for The Best Lawyers in America(R) in ERISA Law ACCESS Newswire
01-Oct-2025 October is Orthodontic Health Month and National Bullying Prevention Month ACCESS Newswire
01-Oct-2025 Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage ACCESS Newswire